Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Simple Search

Search Type: Criteria:

You could also try: beforehand (22), formerly (27), earlier (169)

BRC_Bridging Postdoc Fellowships appform Round 4

Description: NIHR Southampton BRC Bridging Fellowship Funding Application Form Applicant Details: Full name: School & Faculty/Clinical D
Url: /Media/Southampton-Clinical-Research/Downloads/BRC-Bridging-Postdoc-Fellowships-appform-Round-4.doc

MTSc programme 10.5.23

Description: Time 9.00-9.10 Meet the Scientist training day programme Wednesday 10th May 2023 @ LifeLab, Level D, Southampton General Hospital, SO
Url: /Media/Southampton-Clinical-Research/Downloads/MTSc-programme-10.5.23.pdf

Enzalutamide

Description: Chemotherapy Protocol PROSTATE ENZALUTAMIDE Regimen • Prostate-Enzalutamide Indication • Enzalutamide is recommended within its marketing authorisation as an
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Prostatecancer/Enzalutamide.pdf

A1AT deficiency care pathway

Description: WCGS Alpha-1 antitrypsin (A1AT) deficiency care pathway for routine referrals Symptomatic proband with low A1AT plasma concentration OR Famil
Url: /Media/UHS-website-2019/Docs/Services/Genetics/General-genetics/Alpha-1-antitrypsin-referral-pathway.pdf

Giving birth after a caesarean section - patient information

Description: We have written this factsheet to give you more information about the birth options available to you if you have had
Url: /Media/UHS-website-2019/Patientinformation/Pregnancyandbirth/Giving-birth-after-a-caesarean-section.pdf

DH IVIg approved indications full guidance July 2011

Description: DH INFORMATION READER BOX Policy HR / Workforce Management Planning / Clinical Performance Document Purpose Gateway Reference Title Author Publicati
Url: /Media/SUHTExtranet/TrustMedicinesFormulary/Forms/DH-IVIg-approved-indications-Full-Guidance-July-2011.pdf

Papers Trust Board - 10 September 2024

Description: Agenda Trust Board – Open Session Date 10/09/2024 Time 9:00 - 13:00 Location Conference Room, Heartbeat/Microsoft Teams Chair Jen
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/2024-Trust-documents/Papers-Trust-Board-10-September-2024.pdf

Finance and Performance Reports 2023-24 Month 10 - January 2024

Description: Report to the Trust Board of Directors Title: Agenda item: Sponsor: Author: Date: Purpose: Finance Report 2023-24 Month 10 10.
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/2024-Trust-documents/Finance-and-Performance-Reports-2023-24-Month-10-January-2024.pdf

Pemigatinib

Description: Chemotherapy Protocol CHOLANGIOCARCINOMA PEMIGATINIB Regimen  Cholangiocarcinoma - Pemigatinib Indication Pemigatinib for locally advanced or meta
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Hepatobiliary/Pemigatinib.pdf

Paclitaxel (7 day)

Description: Chemotherapy Protocol BLADDER CANCER PACLITAXEL (7 day) Regimen • Bladder Cancer – Paclitaxel (7 day) Indication • Tre
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Bladdercancer/Paclitaxel-7-day.pdf

51 to 60 of 343

Previous … 4 5 6 7 8 … Next